Melanie Gillingham
Director, Master's Program, Graduate Programs in Human Nutrition, School of Medicine · Oregon Health & Science University
Credentials: · ·
History
- 2001–2006
OHSU Department of Molecular and Medical Genetics
Research
Diabetes Care · 2023 · 108 citations
Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates
The FASEB Journal · 2014 · 105 citations
Current issues regarding treatment of mitochondrial fatty acid oxidation disorders
Review · Journal of Inherited Metabolic Disease · 2010 · 100 citations
- CH
31 papers
- MP
11 papers
- JC
10 papers
9 papers
8 papers
- DK
7 papers
- JP
7 papers
7 papers
Grants
- 2021–2026
Exploring the Pathophysiology and Treatment of LCHADD Retinopathy
National Eye Institute · R01
Contact PI · $1.9M · Oregon Health & Science University
- 2019–2025
The Natural History of LCHAD Retinopathy
National Institute of Child Health and Human Development · R01
Contact PI · $2.7M · Oregon Health & Science University
- 2015–2022
Role of Fatty Acid Oxidation Defects in Insulin Sensitivity
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.4M · Oregon Health & Science University
- 2011–2015
Ph 2 Study of Triheptanoin for Tx of Long-Chain Fatty Acid Oxidation Disorder
Food and Drug Administration · R01
Contact PI · $1.2M · Oregon Health & Science University
Clinical trials
- 2021–2022
Principal investigator · Completed
Reneo Pharma Ltd
- 2013–2014
Moderate Intensity Exercise and Phenylketonuria
Principal investigator · Terminated
Oregon Health and Science University
- 2011–2015
Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder
Principal investigator · Completed · Phase 2
Oregon Health and Science University
- 2010–2015
Principal investigator · Terminated
Oregon Health and Science University